Skip Navigation

Docetaxel addition in Metastatic Castrate-Sensitive Prostate Cancer ASPIRE

Brief Summary

Type:
Prostate

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT06931340

Study #:
STUDY00162101

Start Date:
Dec 15, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06931340

View Complete Trial Details & Eligibility at ClinicalTrials.gov